Pennsylvania 2023-2024 Regular Session

Pennsylvania House Bill HB2394

Introduced
6/10/24  
Refer
6/10/24  
Refer
6/12/24  

Caption

Providing for interchange fee tax exclusion and for penalties; and making editorial changes.

Impact

The implications of HB 2394 on state laws include adjustments to how interchange fees are taxed, potentially leading to a decrease in state revenue from these fees. By excluding these fees from taxation, the state may face challenges in maintaining budgetary allocations that are dependent on tax income. Nonetheless, proponents assert that the long-term economic benefits of stimulating business growth and consumer prices could outweigh short-term revenue losses. The bill might also set a precedent for future tax policy concerning financial operations within the state.

Summary

House Bill 2394 addresses the issue of interchange fees by providing a tax exclusion specifically for these fees. This legislative measure aims to reduce the financial burden on businesses that do not pass the costs associated with interchange fees onto consumers. The bill outlines the framework for enforcing this tax exclusion and establishes penalties for non-compliance. The general goal is to create a more favorable economic environment for businesses, particularly in sectors where interchange fees significantly affect operational costs.

Sentiment

The sentiment surrounding HB 2394 appears to be mixed. Supporters, primarily from business sectors, express optimism that this bill will alleviate unnecessary financial burdens and promote a healthier market environment. Conversely, opponents raise concerns about the potential loss in state revenue and question whether such exclusions could disproportionately benefit larger, more established businesses. The overall discourse reflects a balancing act between fostering economic growth and ensuring sufficient public funding.

Contention

Notable points of contention include debates over the potential financial ramifications for the state's tax revenue system and the ethics of exempting certain fees for businesses. Critics argue that tax exclusions should be approached with caution, as they can lead to inequities among different business types and sizes, while proponents focus on the immediate benefits for economic resilience. The discussions also highlight the need for careful analysis of how this bill will impact overall financial regulation and consumer welfare in the long term.

Companion Bills

No companion bills found.

Previously Filed As

PA SB798

Credit card interchange fees; defining terms; requiring certain taxes and fees be excluded from certain interchange fee charges. Effective date. Emergency.

PA SSB1229

A bill for an act excluding interchange fees imposed upon certain taxes at points of sale.

PA HSB324

A bill for an act excluding interchange fees imposed upon certain taxes at points of sale.

PA H650

No Interchange Fees on Sales Tax or Tips

PA S0842

Prohibits the charging of interchange fees on taxes and gratuities.

PA H5554

Prohibits the charging of interchange fees on taxes and gratuities.

PA SB0412

Payment card network interchange fees.

PA HB171

Interchange Fees: Tax & Gratuity

PA S688

Prohibiting card interchange fees on tax or gratuity

PA S0768

Creates the interchange fee restriction act restricting interchange fees on sales and use tax or excise tax when payment is made with a credit or debit card.

Similar Bills

HI HB2254

Relating To Employees.

HI HB1025

Relating To The Center For Cultural And Technical Interchange Between East And West, Inc.

HI SB1344

Relating To The Center For Cultural And Technical Interchange Between East And West, Inc.

NJ S2876

Designates State Highway Route 42 and Interstate Highway Route 295 interchange as "Ensign John R. Elliott Memorial Interchange."

NJ A4127

Designates State Highway Route 42 and Interstate Highway Route 295 interchange as "Ensign John R. Elliott Memorial Interchange."

TX SB190

Relating to the prescription and pharmaceutical substitution of biological products.

IL SB1602

ROAD DESIGNATION PROGRAM ACT

TX SB542

Relating to the prescription and pharmaceutical substitution of biological products.